Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 23 studies | 31% ± 12% | |
astrocyte | 14 studies | 36% ± 16% | |
macrophage | 12 studies | 29% ± 12% | |
microglial cell | 11 studies | 32% ± 11% | |
oligodendrocyte | 11 studies | 30% ± 11% | |
glutamatergic neuron | 9 studies | 43% ± 26% | |
oligodendrocyte precursor cell | 9 studies | 27% ± 11% | |
fibroblast | 8 studies | 25% ± 7% | |
epithelial cell | 7 studies | 28% ± 14% | |
pericyte | 7 studies | 25% ± 7% | |
GABAergic neuron | 7 studies | 46% ± 20% | |
neuron | 6 studies | 41% ± 18% | |
interneuron | 6 studies | 44% ± 21% | |
dendritic cell | 6 studies | 24% ± 5% | |
T cell | 6 studies | 26% ± 7% | |
endothelial cell of lymphatic vessel | 6 studies | 36% ± 10% | |
B cell | 5 studies | 25% ± 8% | |
myeloid cell | 5 studies | 25% ± 8% | |
adipocyte | 5 studies | 26% ± 5% | |
monocyte | 5 studies | 29% ± 6% | |
smooth muscle cell | 5 studies | 23% ± 3% | |
type I pneumocyte | 5 studies | 25% ± 7% | |
type II pneumocyte | 5 studies | 19% ± 5% | |
CD4-positive, alpha-beta T cell | 4 studies | 25% ± 7% | |
granule cell | 4 studies | 23% ± 4% | |
cardiac muscle cell | 4 studies | 20% ± 2% | |
ciliated cell | 4 studies | 21% ± 6% | |
club cell | 4 studies | 22% ± 6% | |
GABAergic interneuron | 3 studies | 28% ± 8% | |
glial cell | 3 studies | 23% ± 9% | |
retinal ganglion cell | 3 studies | 20% ± 1% | |
plasma cell | 3 studies | 25% ± 6% | |
CD8-positive, alpha-beta T cell | 3 studies | 25% ± 5% | |
mast cell | 3 studies | 26% ± 6% | |
retinal cone cell | 3 studies | 19% ± 4% | |
retinal rod cell | 3 studies | 19% ± 2% | |
endothelial cell of vascular tree | 3 studies | 30% ± 14% | |
hepatocyte | 3 studies | 29% ± 10% | |
ependymal cell | 3 studies | 34% ± 16% | |
alveolar macrophage | 3 studies | 38% ± 9% | |
capillary endothelial cell | 3 studies | 24% ± 5% | |
natural killer cell | 3 studies | 28% ± 4% | |
lymphocyte | 3 studies | 47% ± 13% | |
basal cell | 3 studies | 33% ± 18% | |
goblet cell | 3 studies | 35% ± 24% | |
transit amplifying cell | 3 studies | 35% ± 24% | |
mural cell | 3 studies | 37% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3547.26 | 1445 / 1445 | 100% | 28.69 | 183 / 183 |
ovary | 100% | 4669.21 | 180 / 180 | 100% | 25.77 | 430 / 430 |
prostate | 100% | 3165.56 | 245 / 245 | 100% | 27.25 | 501 / 502 |
breast | 100% | 3798.16 | 459 / 459 | 100% | 32.44 | 1113 / 1118 |
lung | 100% | 3518.87 | 578 / 578 | 99% | 24.03 | 1149 / 1155 |
intestine | 100% | 4150.21 | 966 / 966 | 99% | 21.67 | 523 / 527 |
brain | 99% | 2731.40 | 2620 / 2642 | 100% | 42.08 | 705 / 705 |
thymus | 100% | 3781.74 | 653 / 653 | 99% | 36.02 | 599 / 605 |
stomach | 100% | 2234.80 | 359 / 359 | 99% | 25.62 | 283 / 286 |
bladder | 100% | 4226.48 | 21 / 21 | 98% | 18.55 | 495 / 504 |
uterus | 100% | 4300.59 | 170 / 170 | 98% | 20.35 | 449 / 459 |
kidney | 100% | 2704.03 | 89 / 89 | 98% | 27.78 | 881 / 901 |
pancreas | 98% | 2028.35 | 320 / 328 | 98% | 19.72 | 175 / 178 |
skin | 100% | 2518.35 | 1808 / 1809 | 96% | 21.51 | 452 / 472 |
adrenal gland | 100% | 2342.59 | 257 / 258 | 95% | 17.30 | 218 / 230 |
liver | 96% | 1061.42 | 218 / 226 | 81% | 10.13 | 329 / 406 |
adipose | 100% | 3687.16 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5096.87 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 21.09 | 29 / 29 |
spleen | 100% | 3396.66 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 21.63 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.75 | 1 / 1 |
muscle | 99% | 1839.23 | 797 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 2532.39 | 892 / 929 | 0% | 0 | 0 / 0 |
heart | 95% | 1702.28 | 822 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 86% | 11.65 | 69 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008584 | Biological process | male gonad development |
GO_0016567 | Biological process | protein ubiquitination |
GO_0005654 | Cellular component | nucleoplasm |
GO_0036126 | Cellular component | sperm flagellum |
GO_0005634 | Cellular component | nucleus |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | RNF38 |
Protein name | E3 ubiquitin-protein ligase RNF38 (EC 2.3.2.27) (RING finger protein 38) (RING-type E3 ubiquitin transferase RNF38) |
Synonyms | |
Description | FUNCTION: Acts as an E3 ubiquitin-protein ligase able to ubiquitinate p53/TP53 which promotes its relocalization to discrete foci associated with PML nuclear bodies. Exhibits preference for UBE2D2 as a E2 enzyme. . |
Accessions | ENST00000377877.4 [Q9H0F5-4] ENST00000357058.7 [Q9H0F5-3] ENST00000377885.6 [Q9H0F5-3] ENST00000353739.8 [Q9H0F5-2] ENST00000259605.11 [Q9H0F5-1] ENST00000350199.8 [Q9H0F5-3] ENST00000611646.4 [Q9H0F5-4] Q9H0F5 |